D J Lundell

1.5k total citations
27 papers, 1.3k citations indexed

About

D J Lundell is a scholar working on Molecular Biology, Immunology and Renewable Energy, Sustainability and the Environment. According to data from OpenAlex, D J Lundell has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Immunology and 7 papers in Renewable Energy, Sustainability and the Environment. Recurrent topics in D J Lundell's work include Photosynthetic Processes and Mechanisms (9 papers), Light effects on plants (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). D J Lundell is often cited by papers focused on Photosynthetic Processes and Mechanisms (9 papers), Light effects on plants (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). D J Lundell collaborates with scholars based in United States and United Kingdom. D J Lundell's co-authors include Alexander N. Glazer, Gregory Yamanaka, Robley C. Williams, Jay S. Fine, R. William Hipkin, James B. Howard, Aidan K. Curran, Jonathan E. Phillips, Richard W. Chapman and Charles A. Lunn and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and European Journal of Biochemistry.

In The Last Decade

D J Lundell

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D J Lundell United States 20 923 550 269 156 150 27 1.3k
Juan M. Capasso United States 19 777 0.8× 107 0.2× 52 0.2× 59 0.4× 50 0.3× 35 1.2k
Sabine Brugière France 24 2.0k 2.2× 566 1.0× 46 0.2× 44 0.3× 161 1.1× 49 2.6k
René Brunisholz Switzerland 25 1.4k 1.5× 259 0.5× 22 0.1× 30 0.2× 239 1.6× 54 1.8k
Andrei V. Blokhin United States 15 827 0.9× 72 0.1× 74 0.3× 39 0.3× 36 0.2× 35 1.3k
Michel Guertin Canada 35 2.4k 2.6× 174 0.3× 24 0.1× 78 0.5× 150 1.0× 52 3.3k
Sébastien Léon France 24 1.5k 1.6× 159 0.3× 25 0.1× 62 0.4× 70 0.5× 41 1.9k
Tatsunori Okubo Japan 9 437 0.5× 92 0.2× 24 0.1× 253 1.6× 152 1.0× 15 836
C. Luna-Chavez United States 10 979 1.1× 170 0.3× 82 0.3× 32 0.2× 46 0.3× 12 1.4k
Naohiro Oka Japan 16 373 0.4× 137 0.2× 38 0.1× 221 1.4× 39 0.3× 25 898
Akinori Okumura Japan 22 842 0.9× 269 0.5× 8 0.0× 118 0.8× 141 0.9× 52 1.3k

Countries citing papers authored by D J Lundell

Since Specialization
Citations

This map shows the geographic impact of D J Lundell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D J Lundell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D J Lundell more than expected).

Fields of papers citing papers by D J Lundell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D J Lundell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D J Lundell. The network helps show where D J Lundell may publish in the future.

Co-authorship network of co-authors of D J Lundell

This figure shows the co-authorship network connecting the top 25 collaborators of D J Lundell. A scholar is included among the top collaborators of D J Lundell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D J Lundell. D J Lundell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapman, Richard W., Jonathan E. Phillips, R. William Hipkin, et al.. (2008). CXCR2 antagonists for the treatment of pulmonary disease. Pharmacology & Therapeutics. 121(1). 55–68. 171 indexed citations
2.
Lunn, Charles A., Jay S. Fine, Brian J. Lavey, et al.. (2007). Biology and therapeutic potential of cannabinoid CB2receptor inverse agonists. British Journal of Pharmacology. 153(2). 226–239. 101 indexed citations
3.
Kaminski, Henry J., et al.. (1999). Macrophage inflammatory protein-3 beta enhances IL-10 production by activated human peripheral blood monocytes and T cells.. PubMed. 163(9). 4715–20. 19 indexed citations
5.
Wiekowski, Maria, S. Shane Taremi, Anthony Tsarbopoulos, et al.. (1997). Characterization of Potential Antagonists of Human Interleukin 5 Demonstrates Their Cross‐Reactivity with Receptors for Interleukin 3 and Granulocyte‐Macrophage Colony‐Stimulating Factor. European Journal of Biochemistry. 246(3). 625–632. 7 indexed citations
7.
Baum, Charles L., et al.. (1995). Expression and Purification of Two Recombinant Sterol-Carrier Proteins: SCPX and SCP2. Protein Expression and Purification. 6(2). 196–205. 9 indexed citations
8.
Lundell, D J, et al.. (1994). Importance of the loop connecting A and B helices of human interferon-gamma in recognition by interferon-gamma receptor.. Journal of Biological Chemistry. 269(23). 16159–16162. 28 indexed citations
9.
Lunn, Charles A., James Fossetta, David C. Dalgarno, et al.. (1992). A point mutation of human interferon γ abolishes receptor recognition. Protein Engineering Design and Selection. 5(3). 253–257. 20 indexed citations
10.
Lunn, Charles A., et al.. (1992). A point mutation that decreases the thermal stability of human interferon γ. Protein Engineering Design and Selection. 5(3). 249–252. 6 indexed citations
11.
Lundell, D J, Charles A. Lunn, Robert S. Greenberg, et al.. (1990). Exploiting the cell membrane for the production of heterologous proteins in Escherichia coli. Biotechnology and Applied Biochemistry. 12(5). 567–578. 3 indexed citations
12.
Lundell, D J, Alexander N. Glazer, R J DeLange, & D.M. Brown. (1984). Bilin attachment sites in the alpha and beta subunits of B-phycoerythrin. Amino acid sequence studies.. Journal of Biological Chemistry. 259(9). 5472–5480. 49 indexed citations
13.
Schoenleber, Robert, D J Lundell, Alexander N. Glazer, & Henry Rapoport. (1984). Bilin attachment sites in the alpha and beta subunits of B-phycoerythrin. Structural studies on the singly linked phycoerythrobilins.. Journal of Biological Chemistry. 259(9). 5485–5489. 29 indexed citations
14.
Glazer, Alexander N., D J Lundell, Gregory Yamanaka, & Robley C. Williams. (1983). The structure of a «simple phycobilisome. Annales de l Institut Pasteur Microbiologie. 134(1). 159–180. 87 indexed citations
15.
Lundell, D J & Alexander N. Glazer. (1983). Molecular architecture of a light-harvesting antenna. Structure of the 18 S core-rod subassembly of the Synechococcus 6301 phycobilisome.. Journal of Biological Chemistry. 258(2). 894–901. 67 indexed citations
17.
Yamanaka, Gregory, D J Lundell, & Alexander N. Glazer. (1982). Molecular architecture of a light-harvesting antenna. Isolation and characterization of phycobilisome subassembly particles.. Journal of Biological Chemistry. 257(8). 4077–4086. 49 indexed citations
18.
Lundell, D J & James B. Howard. (1981). Isolation and sequences of the cysteinyl tryptic peptides from the MoFe-protein of Azotobacter vinelandii nitrogenase.. Journal of Biological Chemistry. 256(12). 6385–6391. 24 indexed citations
19.
Lundell, D J, Robley C. Williams, & Alexander N. Glazer. (1981). Molecular architecture of a light-harvesting antenna. In vitro assembly of the rod substructures of Synechococcus 6301 phycobilisomes.. Journal of Biological Chemistry. 256(7). 3580–3592. 131 indexed citations
20.
Lundell, D J, Gregory Yamanaka, & Alexander N. Glazer. (1981). A terminal energy acceptor of the phycobilisome: the 75,000-dalton polypeptide of Synechococcus 6301 phycobilisomes--a new biliprotein.. The Journal of Cell Biology. 91(1). 315–319. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026